These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 30005486)

  • 21. Advances in POCT technologies outpace regulatory and accreditation requirements.
    DuBois JA
    MLO Med Lab Obs; 2017 Feb; 49(2):42, 44-5. PubMed ID: 30005487
    [No Abstract]   [Full Text] [Related]  

  • 22. Preface to the special edition of Clin Chem Acta: utilization management in the clinical laboratory.
    Lewandrowski K; Sluss P
    Clin Chim Acta; 2014 Jan; 427():107-8. PubMed ID: 24309229
    [No Abstract]   [Full Text] [Related]  

  • 23. Utilization management in the changing health-care environment.
    Rao SK
    Clin Chim Acta; 2014 Jan; 427():109-10. PubMed ID: 24084508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of the molecular Alere I influenza A&B test compared to that of the xpert flu A/B assay.
    Chapin KC; Flores-Cortez EJ
    J Clin Microbiol; 2015 Feb; 53(2):706-9. PubMed ID: 25502527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of early influenza diagnosis through point-of-care testing in children presenting to an emergency department.
    Li-Kim-Moy J; Dastouri F; Rashid H; Khandaker G; Kesson A; McCaskill M; Wood N; Jones C; Zurynski Y; Macartney K; Elliott EJ; Booy R
    J Paediatr Child Health; 2016 Apr; 52(4):422-9. PubMed ID: 27145506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selected topics in point-of-care testing: whole blood creatinine, influenza testing, fetal fibronectin and patient self-testing in the home.
    Lewandrowski K
    Clin Lab Med; 2009 Sep; 29(3):607-14. PubMed ID: 19840691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical evaluation of rapid point-of-care testing for detection of novel influenza A (H1N1) virus in a population-based study in Spain.
    de la Tabla VO; Antequera P; Masiá M; Ros P; Martin C; Gazquez G; Buñuel F; Sánchez V; Robledano C; Gutiérrez F
    Clin Microbiol Infect; 2010 Sep; 16(9):1358-61. PubMed ID: 21382125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combating inaccuracy and inefficiency in the lab Tips for using logistics to avoid quality control issues.
    Boykin K
    MLO Med Lab Obs; 2016 Oct; 48(10):44. PubMed ID: 30047657
    [No Abstract]   [Full Text] [Related]  

  • 29. Point-of-care testing system enabling 30 min detection of influenza genes.
    Abe T; Segawa Y; Watanabe H; Yotoriyama T; Kai S; Yasuda A; Shimizu N; Tojo N
    Lab Chip; 2011 Mar; 11(6):1166-7. PubMed ID: 21311813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When is rapid testing for influenza useful?
    Hersh AL; Kohn MA; Newman TB
    Clin Infect Dis; 2010 Mar; 50(6):935-6. PubMed ID: 20166825
    [No Abstract]   [Full Text] [Related]  

  • 31. Pre-analytical errors in rapid influenza testing.
    Kelly K
    Clin Infect Dis; 2010 Mar; 50(6):935; author reply 936-7. PubMed ID: 20166824
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of several point-of-care testing (POCT) glucometers with an established laboratory procedure for the diagnosis of type 2 diabetes using the discordance rate. A new statistical approach.
    Püntmann I; Wosniok W; Haeckel R
    Clin Chem Lab Med; 2003 Jun; 41(6):809-20. PubMed ID: 12880146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The real spin on global flu.
    Bersch C; Kateri C
    MLO Med Lab Obs; 2008 Oct; 40(10):14, 17-8, 24-6 passim. PubMed ID: 18988552
    [No Abstract]   [Full Text] [Related]  

  • 34. Early diagnosis of avian influenza.
    Lu PS
    Science; 2006 Apr; 312(5772):337. PubMed ID: 16627701
    [No Abstract]   [Full Text] [Related]  

  • 35. Point-of-care testing for pandemic influenza and biothreats.
    Louie RF; Kitano T; Brock TK; Derlet R; Kost GJ
    Disaster Med Public Health Prep; 2009 Dec; 3 Suppl 2():S193-202. PubMed ID: 19797963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integration between point-of-care cardiac markers in an emergency/cardiology department and the central laboratory: methodological and preliminary clinical evaluation.
    Di Serio F; Amodio G; Varraso L; Campaniello M; Coluccia P; Trerotoli P; Antonelli G; Pansini N
    Clin Chem Lab Med; 2005; 43(2):202-9. PubMed ID: 15843218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of quality indicators to compare point-of-care testing errors in a neonatal unit and errors in a STAT central laboratory.
    Cantero M; Redondo M; Martín E; Callejón G; Hortas ML
    Clin Chem Lab Med; 2015 Feb; 53(2):239-47. PubMed ID: 25153415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of a point-of-care testing program.
    Gregory K; Lewandrowski K
    Clin Lab Med; 2009 Sep; 29(3):433-48. PubMed ID: 19840678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A perspective on laboratory utilization management from Canada.
    Naugler C
    Clin Chim Acta; 2014 Jan; 427():142-4. PubMed ID: 24084502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of rapid point-of-care tests for the detection of avian influenza A(H7N9) virus, 2013.
    Baas C; Barr IG; Fouchier RA; Kelso A; Hurt AC
    Euro Surveill; 2013 May; 18(21):. PubMed ID: 23725980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.